Skip to main content

Quark Biotech and Fujisawa Pharmaceutical Extend Collaboration

NEW YORK, Aug. 6 (GenomeWeb News) - Quark Biotech of Fremont, Calif., and Fujisawa Pharmaceutical of Japan have extended their drug discovery collaboration for an additional year, the companies said today.


The two companies allied on stroke research in 1999, utilizing Quark's high-throughput technology to explore gene and protein functions relating to stroke, screening genes, and devising bioassays to screen small molecule libraries.


Financial details were not provided.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.